PunchaleeK

Thrilled to share our work “Peripheral white cell counts and #mortality across different ILD” at the #ERSCongress2024. Our study includes data from 1,186 patients with fibrotic ILD from @RBandH. Thanks for all support! And many thanks @ActionPFcharity for the conference award

ERJ Open Research: In addition to exacerbation history, numerous factors are known to increase the risk of COPD exacerbations. This prospective study has shown that these predictors differ between mild, moderate and severe/very severe airflow limitation. bit.ly/45og5HC

@ProfJDChalmers Thank you, Prof. Chalmers. I would also like to express my appreciation to you and your collaborators for the publications of cohort data from the EMBARC registry and EMBARC India registry, and to Dr. @hayoungcc for the KMBARC registry data, which were included in my talk.

@PunchaleeK really important topic- well done!

It is my honour to have given a talk on post-tuberculosis bronchiectasis at the 10th Asia Pacific Region Conference of the International Union Against Tuberculosis and Lung Disease (#APRC 2026), held this year in Thailand. #Tuberculosis #bronchiectasis #fibrosis

One of the most important metric for deciding to start a patient on a new treatment is NNT (number-needed-to-treat). Here, Mohsen and I discuss NNT in the context of #dupilumab for #COPD. You will find out the difference btn event vs person-based NNT. bit.ly/3UGhumT

Leading causes of death worldwide, according to the updated GBD report published yesterday. Cardiovascular disease still claims the most lives, with ischemic heart disease and stroke remaining by far the #1 and #2 causes of death, respectively.

Thrilled to have presented two posters at the #ERSCongress2025! 🌎🇳🇱 #ERS Grateful for the engaging discussions. A heartfelt thank you to my supervisor, Prof. Elisabetta A. Renzoni, Prof. Piersante Sestini, Carmel Stock, and all co-authors for their support.

Just in time for the @EuroRespSoc Congress EMBARC is delighted to introduce our downloadable slide decks. Free to use presentation slides on bronchiectasis and recent research. Helping to spread the word and raise awareness of bronchiectasis bronchiectasis.net/downloadable-s…

PAH, when associated with ILD in CTD, worsens prognosis, and poses challenges for treatment Summary of when PAH should be assessed in patients with ILD and when to perform a right heart catheterization by Prof Kuwana @RheumNow #APLAR25

📄 The new ERS & @eular_org clinical practice guideline on connective tissue diseases with ILD involvement has now been published in the European Respiratory Journal. Access the new guideline and associated content via the ERS Respiratory Channel: channel.ersnet.org/media-114675-e…

Emerging evidence suggests air pollution may be associated with abnormalities and disease of the alveoli and pulmonary interstitium. This review examines this evidence alongside mechanisms of alveolar injury, susceptibility factors and knowledge gaps. bit.ly/3GsTO1E

Interstitial lung disease Epithelial damage and ageing: the perfect storm. thorax.bmj.com/content/80/9/6… @RichardJHewitt @LPearmain

INSIDE LOOK 👀 Read from the upcoming issue (September 9): Original research findings support further evaluation of admilparant as a therapeutic option for patients with #IPF or progressive #PF in phase 3 trials. Read more: hubs.la/Q03GsqPh0 #MedEd #JournalCHEST

Just published @ERSpublications The MUSIC trial COPD patients randomized to fluticasone/salmterol (FS), compared with budesonide, had an increase in sputum bacterial load over 3 months Inhaled corticosteroid withdrawal was poorly tolerated in severe COPD publications.ersnet.org/content/erj/ea…

Bridging the Gap: Small Airways, Mechanical Stress, and the Evolution of Emphysema @atscommunity 🔓 Open Access 🔗tinyurl.com/4aecsryj

→ August Arthritis & Rheumatology Clinical Connections ← → Peripheral Biomarker Signatures in Rheumatoid Arthritis–Interstitial Lung Disease → A New Path Forward in SAVI: Blocking the IFN Receptor When Other Strategies Fail acr.tw/46CtCg2

A CHEST research letter evaluates the #epidemiology, demographic data, and health care factors in individuals with a diagnosis of #HermanskyPudlakSyndrome. Read the full article in the July issue of the journal CHEST®: hubs.la/Q03z4DZZ0 #MedEd #JournalCHEST

Pragmatic Comparative Effectiveness Trials in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multiperspective Qualitative Study Read the original research in the June issue of #journal_CHESTPulm: hubs.la/Q03y81Ym0 #MedEd #JournalCHEST

🚨 Just published! A comprehensive and uptodate review on gastrointestinal involvement in systemic sclerosis — Novel mechanisms, diagnosis, and future treatments. 🔗 journals.lww.com/co-rheumatolog… @aegastro @AEEsclerodermia

European Respiratory Review: The immune response to Pneumocystis infection is different in different immune hosts, and this response may be favourable or unfavourable depending on the degree of immunosuppression. bit.ly/4kukdLA

Study of 176 anti-MDA5-DM patients and 55 controls found anti-IFN-α Abs in 18% of MDA5-DM pts, higherin those >60 yrs. IFN-α Ab-positivity assoc w/ RP-ILD (68% vs. 41%) & pulmonary infxn (74% vs. 46%, esp fungi), Mortality (p = 0.006). buff.ly/D2tSXQK